Advertisement

Ads Placeholder
Loading...

Diaceutics PLC

DIUXFPNK
Healthcare
Medical - Diagnostics & Research
$1.67
$0.00(0.00%)
U.S. Market opens in 58h 2m

Diaceutics PLC (DIUXF) Stock Forecast & Price Predictions

Get the latest Diaceutics PLC (DIUXF) stock forecast across short-term and long-term horizons. Meyka AI generates price predictions using advanced models trained on historical data. These forecasts are not investment advice but directional insights to help investors and traders plan strategies.

Model Information

The Forecast Prediction Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full Disclaimer

Monthly Forecast

Predicted Price$1.53
Change↓ $-0.14 (-8.38%)

Quarterly Forecast

Predicted Price$2.09
Change↑ $0.42 (25.15%)

Yearly Forecast

Predicted Price$1.52
Change↓ $-0.15 (-9.06%)

3 Years Forecast

Predicted Price$1.74
Change↑ $0.07 (4.49%)

5 Years Forecast

Predicted Price$1.97
Change↑ $0.30 (17.95%)

7 Years Forecast

Predicted Price$2.29
Change↑ $0.62 (36.87%)

Diaceutics PLC Stock Forecast Summary

Diaceutics PLC (DIUXF) stock is currently priced at $1.67. Based on Meyka AI predictions, the short-term outlook is bearish, with momentum pointing higher. The 1-month projection suggests a move toward $1.53.

In the long term, DIUXF shows a bearish trend. The 2027 forecast points to $1.52 (-9.06% change), while the 2031 forecast suggests $1.97 (17.95% change). Looking 7 years ahead, projections estimate the stock could trade near $2.29, a 36.87% change from today’s price.

Overall Sentiment

Bearish

Short-Term Outlook

Bearish

Long-Term Outlook

Bearish

This mix indicates that Diaceutics PLC stock is expected to trade sideways over the coming years.

Investment Calculator

Estimate your potential returns on DIUXF based on our AI price forecasts. Enter your investment amount and select a target date.

Based on your investment of $1,000.00 in Diaceutics PLC and holding until April 4th, 2027, you could make a potential $90.62 loss, reflecting a -9.1% ROI over the next 365 days.

$

$Shares Bought

598.8024

@ $1.67/share

~Forecast Price

$1.52

1-year AI forecast

$Est. Portfolio Value

$909.38

$90.62 loss

%ROI

-9.1%

return on investment

Diaceutics PLC yearly Price Forecast Chart

Explore the yearly forecast chart for DIUXF, which maps expected price movement, support levels, and resistance targets. The dropdown lets you view forecasts across multiple horizons, from short-term daily trends to 7-year projections, helping investors evaluate Diaceutics PLC over different timeframes.

No forecast data available

No prediction data found for this time period.

empty-state-iconForecasting data is not available for DIUXFForecasting details for DIUXF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Diaceutics PLC Stock Forecast 2026

The forecast for Diaceutics PLC (DIUXF) in 2026 suggests a price of $1.52, representing a -9.06% move from today’s price.

Average Target: $1.52

Market Outlook: bearish based on current trend indicators.

Key Drivers in 2026:
  • Earnings growth projections.
  • Competitive performance in the Healthcare.
  • Macroeconomic factors such as interest rates and inflation.

Diaceutics PLC Stock Forecast 2030

By 2030, Meyka AI projects DIUXF could trade near $1.97, showing a potential 17.95% compared to current levels.

Average Target: $1.97

Market Outlook: bullish.

What could influence the 2030 forecast:
  • Technological innovation and product cycles.
  • Expansion into global markets.
  • Long-term investor sentiment toward Diaceutics PLC.

Diaceutics PLC 7-Year Stock Forecast (20322033)

Looking 7 years ahead, the long-term forecast for DIUXF points to a price around $2.29, which is a projected 36.87% move from today’s level.

Average Target: $2.29

Outlook: bullish, depending on macroeconomic conditions and sector growth.

Long-Term Drivers:
  • Global economic expansion or contraction.
  • Regulatory and policy environment.
  • Diaceutics PLC’s ability to maintain market leadership.

Frequently Asked Questions